We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CATY icon
1826
Cathay General Bancorp
CATY
$4.23B
$2.76M 0.01%
+61,681
New +$2.84M
LLAP.WS
1827
CALL
DELISTED
Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
LLAP.WS
$2.75M 0.01%
+399,996
New +$234K
SUMO
1828
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$2.75M 0.01%
235,900
+93,604
+66% +$1.08M
HMHC
1829
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$2.75M 0.01%
130,717
+28,205
+28% +$532K
RTLR
1830
DELISTED
Rattler Midstream LP Common Units
RTLR
$2.75M 0.01%
196,651
-436,104
-69% -$5.66M
ACQRW
1831
CALL
DELISTED
Independence Holdings Corp. Warrant
ACQRW
$2.74M 0.01%
279,997
GNR icon
1832
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.73B
$2.73M 0.01%
+43,538
New +$2.55M
CORZW
1833
CALL
DELISTED
Core Scientific, Inc. Warrant
CORZW
$2.73M 0.01%
332,136
-66,614
-17% -$156K
GDEVW icon
1834
CALL
GDEV Inc Warrant
GDEVW
$2.73M 0.01%
427,197
SEMR
1835
DELISTED
Semrush
SEMR
$2.72M 0.01%
227,840
-173,746
-43% -$2.61M
ARBGW
1836
CALL
DELISTED
Aequi Acquisition Corp warrants
ARBGW
$2.72M 0.01%
276,661
AVPTW
1837
CALL
DELISTED
AvePoint Inc Warrant
AVPTW
$2.71M 0.01%
514,791
+14,791
+3% +$14.1K
QS icon
1838
QuantumScape Corp
QS
$3.1B
$2.71M 0.01%
135,369
-83,764
-38% -$1.44M
REGN icon
1839
Regeneron Pharmaceuticals
REGN
$72.9B
$2.7M 0.01%
3,867
-125,161
-97% -$79.2M
SOXX icon
1840
PUT
iShares Semiconductor ETF
SOXX
$38.9B
$2.7M 0.01%
17,100
-101,700
-86% -$16.3M
BBDC icon
1841
Barings BDC
BBDC
$877M
$2.7M 0.01%
260,837
-28,654
-10% -$307K
SPECW
1842
CALL
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$2.69M 0.01%
269,722
+119,723
+80% +$37.1K
MODN
1843
DELISTED
MODEL N, INC.
MODN
$2.69M 0.01%
100,008
+28,909
+41% +$754K
CBRGW
1844
CALL
DELISTED
Chain Bridge I Warrants
CBRGW
$2.69M 0.01%
+270,399
New +$113K
WRAC.WS
1845
CALL
DELISTED
Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
$2.69M 0.01%
269,768
SONY icon
1846
Sony
SONY
$137B
$2.69M 0.01%
130,915
+59,980
+85% +$1.3M
S icon
1847
SentinelOne
S
$6.32B
$2.69M 0.01%
69,283
-440,039
-86% -$18M
ORIA
1848
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$2.68M 0.01%
274,975
Y
1849
DELISTED
Alleghany Corp
Y
$2.68M 0.01%
+3,163
New +$2.19M
HYMC icon
1850
Hycroft Mining Holding Corp
HYMC
$1.74B
$2.68M 0.01%
+116,620
New +$867K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.